Abstract 3D bioprinting enables rapid fabrication of complex biological structures for tissue engineering applications. However, optimizing bioink formulation remains challenging due to complex relationships among material properties, printability, and cell viability. While the perimeter ratio (Pr) is commonly used to evaluate printability, it cannot adequately capture the full geometric fidelity required for comprehensive printability assessments, limiting robust bioink design. To address this limitation, a novel Hausdorff distance (HD) metric is employed to quantify printability, directly measuring the maximum deviation between the designed and printed structures. Furthermore, multiple machine-learning approaches were applied to alginate-hyaluronic acid (ALG-HA) composite inks and rat pheochromocytoma-derived PC12 cells to assess printability and cell viability. Rheological parameters were characterized using support vector regression (SVR) with R² ≥ 0.974. Multi-layer perceptron (MLP) regressors achieved R² values of 0.932 and 0.945 when predicting HD values of printed grid structures and cell viability, respectively. A regression-based convolutional neural network (CNN) was developed to predict HD values directly from grid structure images, achieving an R² of 0.986. Through optimization, optimal as-extruded cell viability (≥ 95%) can be achieved while maintaining high printability (HD ≤ 0.20). The optimal ink composition was further verified with good long-term cell viability and proliferation potential. This proposed AI-integrated approach can dramatically reduce ink optimization time by rapidly predicting rheological properties, printability, and cell viability from minimal experimental data.
Zhang et al. (Fri,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: